Supplementary Data from Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia
Franca Raucci(IFOM), Valter D. Longo(University of Southern California), Claudio Vernieri(Fondazione IRCCS Istituto Nazionale dei Tumori), Euplio Visco(IFOM), Olga Blaževitš(IFOM), Stefano Casola(IFOM), Gabriele Varano(IFOM), Roberta Buono(University of California, Irvine), Samuel Lazzeri(IFOM), Maira Di Tano(University of Milan), Giuseppe Fragale(IFOM), Giulia Salvadori(University of Milan), Francesca Ligorio(Fondazione IRCCS Istituto Nazionale dei Tumori), Anastasiya Shmahala(IFOM), Filippo de Braud(University of Milan)
Cited by 0
Related Papers
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k
Regulation of the Germinal Center Response by MicroRNA-155
|Science|2007|1.5k
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|835
Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination
|Nature Immunology|2006|771
Association of Animal and Plant Protein Intake With All-Cause and Cause-Specific Mortality
|JAMA Internal Medicine|2016|718